TIRZEPATIDE 30MG

Tirzepatide 30mg

Tirzepatide is a next-generation peptide developed as a dual receptor agonist, activating both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) pathways. This dual incretin activity is the focus of research into blood sugar regulation, weight loss mechanisms, and metabolic balance. With higher-strength formulations such as this 30mg option, Tirzepatide is of interest for studies requiring extended dosing potential.

Research Highlights

GLP-1 Receptor
Studied for glucose metabolism, appetite suppression, and satiety response.

GIP Receptor
Researched for insulin sensitivity, fat metabolism, and energy regulation.

Metabolic Pathways
Explored for roles in weight management, cardiovascular support, and lipid health.

Why Choose Tirzepatide from GeoPeptides?

≥99% purity, laboratory verified
Dual-pathway incretin research compound
Manufactured in the USA
Fast, discreet worldwide shipping

Product Details

Compound: Tirzepatide
Strength: 30mg lyophilized peptide
CAS: 2023788-19-2
Molecular Formula: C225H348N48O68
Molecular Weight: 4813.55 g/mol
Appearance: Clear
Form: Single vial

Reviews

TIRZEPATIDE 30MG

Tirzepatide 30mg – Research Peptide